Abstract
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide, and early diagnosis, treatment, and management are essential for reducing the burden of these diseases. This systematic review provides an update on recent developments in the field of CVDs, including the use of artificial intelligence (AI) in diagnosis and management, advances in genetic testing and precision medicine, the role of telemedicine and remote monitoring technologies, novel therapies such as gene therapy and cell therapy, and the importance of addressing mental health in the prevention and management of CVDs. Advances in genetic testing and precision medicine have enabled personalized treatment of CVDs, with pharmacogenomic approaches helping to identify the most effective medications for individual patients. Telemedicine and remote monitoring technologies have shown promise in improving the management of CVDs, allowing for real-time data collection and early detection of complications. Novel therapies such as gene therapy and cell therapy are being explored for the treatment of CVDs, with early studies showing promising results. Overall, the recent developments in the diagnosis, treatment, and management of CVDs highlight the ongoing efforts to improve patient outcomes and reduce the burden of these diseases.
Keywords
Novel therapies, Biomarkers, Personalized medicine, Cardiovascular, Artificial intelligence